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Background: The chloride channel CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) is expressed by many cell types, including
hematopoietic stem/progenitor cells (HSPCs). In this study, we sought to better comprehend the regulation of CFTR activity in HSPCs, namely by
beta-adrenergic stimuli.
Methods: The expression of β2-adrenergic receptor (β2-AR) in murine Sca-1
+ HSPCs was investigated by immunoﬂuorescence/confocal
microscopy and ﬂow-cytometric analysis. Association with CFTR was assessed by immunoprecipitation. HSPCs were evaluated for ATP content
and CFTR activity by means of luminometric and spectroﬂuorometric methods, respectively, upon stimulation with salbutamol.
Results: HSPCs express β2-AR over the whole plasma membrane and are associated in cellula with both the immature and mature forms of CFTR.
β2-AR was predominantly expressed by HSPCs with bigger size. CFTR channel activity was increased by salbutamol treatment and this activation
was inhibited by either a speciﬁc CFTR inhibitor (CFTRinh172) or a β2-AR receptor inhibitor (ICI 118,551). Intracellular ATP levels were reduced
by salbutamol stimulation and this effect was reversed when ICI 118,551 or CFTR inhibitors were present. A trend in the increase of extracellular
ATP upon salbutamol stimulation was observed.
Conclusions: In HSPCs, CFTR is regulated by β2-adrenergic receptor stimulation determining intracellular ATP depletion.
© 2014 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
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1569-1993/© 2014 European Cystic Fibrosis Society. Published by Elsevier B.V. Adysfunction causes cystic fibrosis (CF). Although initially shown
to be expressed in epithelia of various organs with secretory/
absorptive function, further studies have demonstrated CFTR
expression and/or function in cells of hematopoietic origin,
particularly in polymorphonuclear leukocytes [1], macrophages
[2,3], and platelets [4]. Recently, we have shown that CFTR is
expressed at the mRNA and protein levels in hematopoietic stem/
progenitor cells (HSPCs) and that its activation is inhibited byll rights reserved.
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metabolism and its function [5]. Furthermore, our data show that
CFTR is expressed at low levels in a subset of HSPCs with bigger
size, which is characterized also by low mitochondrial content [5].
CFTR is a member of the ATP binding cassette family and
functions as a cAMP-activated chloride channel [6]. In airway
epithelial cells, CFTR activity is physiologically regulated by
β-adrenergic stimuli. The activation of β2-adrenergic receptors
(β2-AR) is able either to stimulate CFTR channel activity [7] or
to increase its expression on the apical surface [8]. Since this
aspect of CFTR regulation has not been studied in cells of
hematopoietic origin, we sought to evaluate CFTR activity in
HSPCs upon β-adrenergic stimulation and correlate this with
the intracellular ATP content.
2. Materials and methods
2.1. HSPC isolation
The experiments were performed using 6–8 weeks old male
C57Bl/6 mice (Charles River Laboratories, Calco, Italy) with a
body weight of 23–27 g. They were housed and handled
according to institutional guidelines which comply with Italian
legislation and were given food and water ad libitum. HSPCs
were isolated from femurs and tibiae of C57Bl/6 mice as
previously described [5]. The animals were killed by sodium
pentothal hyperanaesthesia, both ends of the femur and tibia were
removed and the bone marrow was flushed out with PBS using a
needle. The recovered total bone marrow cells were filtered
(CellTrics 100 mm, Partec, Münster, Germany), centrifuged,
washed and re-suspended in PBS supplemented with 2% FBS
and 1 mMEDTA. The total number of cells was determined with
a Bürker's cytometer. Positive selection of bone marrow stem/
progenitor cells by EasySep (Mouse Sca1 selection kit; StemCell
Technologies) was done according to the manufacturer's
instructions. Briefly, recovered total bone marrow cells were
incubated with the PE-conjugated anti-Sca-1 antibody. Then
tetrameric antibody complex, which recognizes both PE and
dextran, was added, which was followed by addition of dextran
coated magnetic nanoparticles. Magnetically labeled target cells
were then separated from unlabeled unwanted cells using the
EasySep magnet by pouring the unlabelled cells off. 3–4 mice
were used to obtain a pool of HSPCs.
2.2. Immunostaining and cytofluorimetric analysis of
β2-adrenergic receptor
Aliquots of 2 × 105 Sca-1+ HSPCs were pelleted by
centrifugation at 337 ×g for 10 min at +4 °C, fixed in PBS
containing 3% paraformaldehyde and 2% sucrose for 5 min at
room temperature, permeabilized with ice cold Triton Hepes
buffer (20 mM HEPES, 300 mM sucrose, 50 mM NaCl, 3 mM
MgCl2, 0.5% Triton X-100, pH 7.4) for 5 min at room
temperature and then were incubated with rabbit polyclonal
anti β2-AR antibody [clone: H-20] (Santa Cruz Biotechnology,
CA) at +4 °C overnight. The cells were then pelleted and
washed with PBS to remove excess unbound primary antibodyprior to incubation with a FITC-conjugated secondary antibody
(anti-rabbit IgG, used at 1:80, Sigma-Aldrich, Milan, Italy) for
90 min at room temperature. An isotype control antibody
(normal rabbit IgG, Santa Cruz Biotechnology, CA) was also
used as negative control. After incubation, the cells were
pelleted, washed twice with PBS and analyzed by fluorescence-
activated cell sorting (FACS) with a EPICS XL MCL flow
cytometer (Beckman Coulter Fullerton, CA, USA) to determine
the percentage of cells expressing β2-AR.
2.3. Confocal microscopy
Forβ2-AR detection, Sca-1
+ HSPCs were labeled withβ2-AR
antibody following the same protocol as for cytofluorimetry. An
aliquot (1 × 105 cells/ml) of the preparation was cytospun onto
glass slides and incubated with propidium iodide (diluted at
1:5000 of 1 mg/ml stock solution) for 5 min at 37 °C, and
washed. The slides were mounted and observed through the FITC
(excitation 488 nm, emission 516 nm) and TRITC (excitation
544 nm, emission 620 nm) filters. Cells were analyzed using
Nikon TE2000 microscope coupled to a Radiance 2100 confocal
dual-laser scanning microscopy system (Bio-Rad, Segrate, Italy).
Specimens were viewed through a 60× oil immersion objective
and zoomed at 2.0×. Digital images were processed using the
program Laser Sharp 2000 (Bio-Rad).
For CFTR detection, 1 × 106 Sca-1+ HSPCs were pelleted by
centrifugation at 337 ×g for 10 min at +4 °C, fixed in PBS
containing 3% paraformaldehyde and 2% sucrose for 5 min at
room temperature, permeabilized with ice cold Triton Hepes buffer
(20 mM HEPES, 300 mM sucrose, 50 mM NaCl, 3 mM MgCl2,
0.5% Triton X-100, pH 7.4) for 5 min at room temperature and
then were incubated with Ab anti-CFTR (MAb 25031 mouse
IgG2a, R&D Systems, Milan, Italy) at +4 °C for 60 min, at
dilution of 1:500. The cells were then pelleted and washed with
PBS to remove excess unbound primary antibody prior to
incubation with a FITC-conjugated secondary antibody (anti-
mouse IgG, used at 1:100, Sigma-Aldrich, Milan, Italy) for 45 min
at +4 °C. As negative control, cells were incubated only with the
secondary antibody. An aliquot (1 × 105 cells/ml) of the prepara-
tion was cytospun onto glass slides, observed through the FITC
and TRITC filters, and analyzed as described before.
2.4. Immunoprecipitation and Western blotting
Sca-1+ HSPCs and Calu-3 cells were lysed with RIPA buffer
(Sigma-Aldrich), and 500–1000 μg of cell lysate was immuno-
precipitated overnight at +4 °C on a mixer using protein A
agarose beads and an appropriate dilution of anti β2-AR anti-
body (2 μg) or anti-CFTR antibody (2 μg). After washing,
the immunoprecipitated proteins were electrophoresed through
4–12% or 8–16% polyacrylamide gel (mini-protean TGX gels,
Bio-Rad), and transferred onto blotting membrane (trans-Blot
Transfer Medium pure nitrocellulose cat 162-0115, Bio-Rad).
The blots were incubated with β2-AR antibody (1:100) or
anti-CFTR antibody (1:500). The primary Abs were counter-
stained by a HRP-conjugated anti-IgG Ab (anti-rabbit and
anti-mouse 1:10,000, Bio-Rad) for 60 min at room temperature.
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Western C Kit, Bio-Rad).
2.5. CFTR chloride channel activity
Chloride efflux was measured using the method implemented
in [9]. Cells seeded on 0.1% gelatin coated glass coverslips were
loaded overnight in culture medium containing 5 mM MQAE;
after 12 h, coverslips were inserted into a perfusion chamber
and superfused continuously and fluorescence was recorded with
a Cary Eclipse Varian spectrofluorometer. In all the experiments,
cells were perfused at 37 °C using alternatively two different
HEPES-buffered bicarbonate-free media, (i) a Cl− medium
(135 mM NaCl, 3 mM KCl, 1.8 mM CaCl2, 0.8 mM MgSO4,
20 mM HEPES, 1 mM KH2PO4, 11 mM glucose), and (ii) a
NO3 medium (135 mMNaNO3, 3 mMKNO3, 0.8 mMMgSO4,
1 mM KH2PO4, 20 mM HEPES, 5 mM Ca(NO3)2, 11 mM
glucose). The measurement of chloride efflux was carried out
after replacement of the Cl− medium by the NO3
− medium. The
rates of chloride efflux were calculated by linear regressionFig. 1. Immunofluorescence and confocal microscopy of β2-AR in HSPCs. Sca-1
+
anti-rabbit antibody. Finally, cells were labeled with propidium iodide (PI). Panel A
HSPCs without labeling with anti β2-AR antibody and panel C merge. Panel D sh
channel (Panel E) is shown. The figure represents images of the overlapped confoca
many HSPC different samples. Continue and dotted white arrows point to smaller
10 μM.analysis of the first 30 points taken at 4 s intervals while the
change of fluorescence was still linear. CFTR-dependent chloride
efflux was evaluated as the difference in fluorescence intensity
induced by 1 μM salbutamol (Sigma-Aldrich, Milan, Italy) plus
IBMX (500 μM) or salbutamol alone, in the absence and
presence of either of the CFTR inhibitors, glibenclamide (Sigma-
Aldrich; 100 μM) or CFTRinh172 (Calbiochem; 5 μM). The effect
of β2-AR inhibition on CFTR-dependent chloride efflux was
studied by adding ICI 118,551 hydrochloride (Sigma-Aldrich,
10 μM) for 5 min before salbutamol plus IBMX addition.
2.6. ATP levels
To study intracellular ATP level, 1 × 104 HSPCs were
incubated with salbutamol (1 μM) for 20 min after pre-
treatment or not with ICI 118,551 hydrochloride (10 μM) for
20 min or glibenclamide (100 μM) or CFTRinh172 (5 μM) for
10 min. The incubation with DMSO for 40 min at the final
dilution of 1:10 was used as control condition. All the incubations
were performed at 37 °C.HSPCs were labeled with anti β2-AR antibody and then with FITC-conjugated
represents negative control without primary antibody. Panel B shows Sca-1+
ows the staining with anti β2-AR antibody and in panel F merge with the red
l planes and is representative of three different experiments carried out with as
and bigger cells respectively. Panels have been obtained with 2.0× zoom. Bar:
29T. Trotta et al. / Journal of Cystic Fibrosis 14 (2015) 26–33The ATP cytosolic content was measured by using the
luciferin/luciferase (rL/L) reaction (Enliten ATP assay, Promega,
Madison, WI) [10]. Briefly, HSPCs were spun at 12,000 ×g for
10 min, the supernatant was stored at −80 °C, while 200 μl of
ATP-free boiling water was added to the pellet. Cell lysate was
spun at 12,000 ×g per 5 min, and 20 μl of supernatant was added
to 100 μl of the rL/L reagent and read at the luminometer TD-20/
20 DL-Ready (Turner Design Instruments, Sunnyvale, CA) at the
wavelength of 560 nm. Samples were compared to a standard
curve obtained adding various amounts of ATP (from 1 × 10−7
to 1 × 10−11 M) to the rL/L reagent. To assess extracellular ATP
levels, 1 × 104 HSPCs were treated with salbutamol (1 μM)
20 min after pre-treatment or not with ICI 118,551 hydrochloride
(10 μM) for 20 min (or DMSO in control cells). HSPCs were
spun at 12,000 ×g for 10 min and 20 μl of supernatant was used
to measure the ATP content by the luciferin/luciferase (rL/L)
reaction.2.7. Statistical analysis
Data are shown as mean ± SEM. Statistical significance was
studied by the ANOVA with Tukey's Multiple Comparison
Test or paired Student's t test where appropriate. All data wereFig. 2. Flow cytometry analysis of β2-AR in HSPCs. Sca-1
+ HSPCs were labeled wit
analyzed by cytofluorimetry. Panel A depicts the dot plot analysis of the whole HSPC
scatter side and named R1 the biggest and R2 the smallest. Panel B shows representat
expression. Panel C shows the percentage of β2-AR-positive cells in the whole popu
the mean ± SEM. *p b 0.05, **p b 0.01, and ***p b 0.001.analyzed using Prism 4 (GraphPad Software, Inc., La Jolla,
CA). p values less than 0.05 were considered significant.
3. Results
3.1. β2-Adrenergic receptor expression by HSPCs
Having demonstrated in a previous study that Lin− Sca-1+
HSPCs do express a functional CFTR on their plasma membrane
[5], we confirmed the presence of the CFTR protein on the plasma
membrane by immunofluorescence. Fig. S1 shows that the
CFTR signal was localized onto the surface of HSPCs and over-
lapped that of the Sca-1 antigen. Then, we sought to determine
whether these cells could also express β2-AR. Confocal micros-
copy on cells labeled with double staining revealed that most
of the HSPCs expressed β2-AR. Analysis of the images recon-
structed from the overlapped confocal planes displayed that the
β2-AR-related fluorescence was diffused over the whole plasma
membrane (Fig. 1D). The stainingwas localizedmostly in HSPCs
with bigger size, while smaller cells showed low or null β2-AR
expression (Fig. 1F).
To investigate this in a more quantitative way, we analyzed
β2-AR expression by flow cytometry. As in our previous work,
we identified two subpopulations, based on the size (forwardh anti β2-AR antibody and then with FITC-conjugated anti-rabbit antibody, and
population, denoting two subsets of cells, distinguishable for their forward and
ive histograms for the ungated, R1 and R2 subpopulations as concerning β2-AR
lation, R1 and R2 subsets obtained in three experiments. Data are represented as
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expressed β2-AR in 34 ± 7.8% of the whole population, the
expression of β2-AR was found to differ in these two subsets of
cells. The subpopulation with bigger size (R1) expressed more
β2-AR (in 76.2 ± 13.8% of cells) than the smaller R2 sub-
population (5.4 ± 3.5%) (Fig. 2B and C).
It was then studied if β2-AR and CFTR were interacting in
HSPCs. Calu-3, an epithelial cell line derived from submucosal
gland, was used as positive control since it has been already
shown that β2-AR and CFTR interact with each other in this cell
line [7]. Western blotting for CFTR showed a predominant
mature form of CFTR in Calu-3 cells as compared with immature
form of CFTR in agreement with previous studies [11,12] (not
shown). HSPCs displayed both immature and mature forms, as
previously demonstrated [5]. Immunoprecipitation analysis of
protein cell extract with anti-β2-AR-Ab revealed that β2-AR and
CFTR interacted in cellula in both Calu-3 and HSPCs (Fig. 3A).
In HSPCs, both immature (band B) and mature (band C) forms of
CFTR were associated with β2-AR. Fig. 3B shows that the same
results were obtained when cell lysates were immunoprecipitated
with the anti-CFTR antibody and blotted with either the anti-
β2-AR or the anti-CFTR antibody. These data indicate that CFTR
and β2-AR are physically associated in HSPCs.Fig. 3. Immunoprecipitation of β2-AR and CFTR in Calu-3 and Sca-1
+ HSPCs.
A) The cell lysates were incubated with a mixture of protein A agarose beads
and the polyclonal anti β2-AR antibody. The precipitates were resolved via
SDS-PAGE and proteins were blotted to nitrocellulose membrane. Blots were
then incubated with an anti-CFTR antibody (upper panel) or an anti β2-AR
antibody (lower panel) followed by incubation with the relevant secondary
antibody. B) The immunoprecipitation was performed as in A) but with the
anti-CFTR antibody. Blots were incubated with the anti-CFTR antibody (upper
panel) or the anti β2-AR antibody (lower panel) followed by incubation with the
relevant secondary antibody. Blots were visualized by chemiluminescence. One
out of three experiments is shown.3.2. Activation of CFTR by β2-AR stimulation
As in other cell types [9,13,14], Sca-1+ HSPCs exhibited a
basal chloride efflux when chloride was replaced by nitrate
(first slope of the trace in Fig. 4A and C, and first bar in Fig. 4B
and D). Moreover, we previously showed that Sca-1+ HSPCs
display CFTR-dependent chloride secretion upon activation by
forskolin, an adenylyl cyclase activator, plus IBMX, a phos-
phodiesterase inhibitor [5]. Here we evaluated the ability of
β2-AR to activate CFTR in HSPCs using the β2-AR agonist,
salbutamol, either combined or not with IBMX. Fig. 4 illus-
trates a typical experiment (A and C) and the summary of
several experiments (B and D) of chloride efflux in Sca-1+
HSPCs seeded on glass coverslips. Stimulation of β2-AR with
salbutamol (1 μM) plus IBMX (second slope of the trace in
Fig. 4A and C, and second bar in Fig. 4B and D) significantly
increased chloride efflux compared to basal levels. The addition
of the specific CFTR inhibitor, CFTRinh172 [15], 2 min before
as well as in the presence of salbutamol plus IBMX in NO3
medium (third slope of the trace in Fig. 4A, and the third
bar in Fig. 4B), inhibited the chloride efflux salbutamol plus
IBMX dependent increase. Similar results were obtained when
glibenclamide, a less specific CFTR inhibitor [9], was used
as CFTR inhibitor (data not shown). The amount of CFTR-
dependent chloride efflux, defined as the difference between
the rates of salbutamol plus IBMX-stimulated chloride efflux
before and after CFTRinh172 treatment, was similar to that
previously observed by us in the same cells treated with
forskolin plus IBMX [5]. To confirm that this effect was due to
activation of the β2-AR, we studied the reversibility of the
salbutamol effect with ICI 118,551 hydrochloride, a highly
specific β2-AR antagonist. As can be seen from the represen-
tative trace of Fig. 4C and the summary in Fig. 4D the
pre-incubation with ICI 118,551 hydrochloride (10 μM) for
5 min before salbutamol plus IBMX addition (third slope of the
trace in Fig. 4C, and the third bar in Fig. 4D) inhibited the
increase of chloride efflux. Importantly, these results indicate
that the entity of the chloride efflux inhibition obtained after
treatment with the CFTR blocking agent is comparable to that
obtained after treatment with β2-adrenergic receptor antagonist,
thus suggesting that this receptor plays an important role in
modulating the CFTR activity in Sca-1+ HSPCs.
Notably, control experiments showed that IBMX was
dispensable to elicit the salbutamol-mediated CFTR-linked chlo-
ride efflux (salbutamol + IBMX: 0.0338 ± 0.004 Δ(F/F0)/min,
salbutamol: 0.0292 ± 0.0024 Δ(F/F0)/min, n = 4, p N 0.05).
Moreover and consistently, IBMX alone did not cause any
change of the CFTR-linked chloride efflux (IBMX (500 μM)
0.0224 ± 0.0035; IBMX + CFTR inhibitor 172 (5 μM) 0.0181 ±
0.0030Δ(F/F0)/min, n = 3, p N 0.05). Thereby, we conclude that
salbutamol is sufficient alone to stimulate CFTR-dependent efflux
in HSPCs.
3.3. Reduction of intracellular ATP levels by salbutamol
Next, we sought to investigate the mechanism of the
activation of CFTR by salbutamol. It has been already shown
Fig. 4. Effect of salbutamol on the CFTR activity. (A) Typical recordings showing changes in intracellular Cl− dependent MQAE fluorescence (expressed as the F/F0
ratio) when HSPCs were incubated in the presence of salbutamol (1 μM) and IBMX (500 μM), added without and with CFTRinh172 (5 μM). (B) Summary of the data
collected from 6 independent experiments. The first bar represents a basal chloride efflux under baseline conditions when chloride was replaced by nitrate.
CFTR-dependent chloride efflux (fourth bar) was calculated as difference between fluorescence intensity obtained after treatment with salbutamol plus IBMX in the
absence (second bar) and in presence of CFTRinh172 (third bar). (C) Typical trace showing changes in intracellular Cl
− when the cells were treated with salbutamol
(1 μM) and IBMX (500 μM), in the absence or presence of ICI 118,551 hydrochloride (10 μM). (D) Summary of the data collected from 3 experiments. β2-AR
regulated chloride efflux (fourth bar) was calculated as difference between fluorescence intensity obtained in the absence (second bar) and in presence of ICI 118,551
hydrochloride (third bar). Data are expressed as the mean ± SEM. Statistical comparison was made using paired Student's t test with respect to the basal chloride
efflux when chloride was replaced by nitrate. In B) and D), Salb + IBMX vs NO3: **p b 0.01.
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both increased CFTR expression and cAMP levels [8]. To this
end, we evaluated whether salbutamol have some effect on
ATP levels. Salbutamol treatment reduced ATP content of
HSPCs by ~33% (Fig. 5A). By exposing HSPCs to ICI 118,551
hydrochloride, together with salbutamol, ATP content was similar
to that of control cells. Thus, we checked whether the channel
activity of CFTR was involved in the ATP depletion. Our data
show that both glibenclamide and CFTRinh172 resumed intracel-
lular ATP levels when added to HSPCs together with salbutamol
(Fig. 5A). Assessment of the extracellular ATP content resulted in
values approximately 75 fold lower than the intracellular ATP
concentration when normalized to the same cell number (Fig. 5B).
Salbutamol treatment increased extracellular ATP levels by
~23%, which was completely prevented by pre-incubation of
cells with ICI 118,551 (Fig. 5B). The observed differences in
the extracellular ATP level were at the border of statistical
significance.
4. Discussion
There is an increasing evidence that CFTR can interact with a
number of membrane-anchored and intracellular proteins [16].Membrane-anchored protein interactions stabilize CFTR on the
plasmamembrane, allowing its main function of chloride channel,
implicated in the fluid and ion homeostasis in absorbing/secreting
epithelia. Intracellular protein interactions allow correct CFTR
folding, trafficking and function. Thus, CFTR functions are
believed to be more complex than thought before. Indeed, CFTR
has been implicated in many cellular functions [17].
The β2-adrenergic receptor is involved in CFTR activation by
raising cAMP intracellular levels and mediating protein kinase A
(PKA) activation. In airway epithelial cells, the interaction of
β2-AR with CFTR is mediated by scaffold proteins, such as
NHERF1, allowing its interaction with PKA and stabilizing it on
the plasma membrane [7]. We have previously shown that CFTR
is expressed by murine HSPCs and that its expression is
correlated with the mitochondrial content, i.e. the higher the
mitochondrial content the higher the CFTR levels [5]. The
biological significance of this correlation is unknown at the
moment, thus in this work we have further explored the role
of CFTR in HSPCs. We show that HSPCs express β2-AR,
confirming previously published results [18]. Moreover, similar-
ly with airway epithelial cells, β2-AR interacts with the mature
form of CFTR. NHERF1 is expressed by c-kit+/Lin−/Sca-1+
HSPCs and has been shown to be an intracellular ligand for
Fig. 5. Effect of salbutamol on ATP levels. A) HSPCs were treated with 1 μM
salbutamol (or DMSO in control cells) in the absence or presence of ICI 118,551
hydrochloride, glibenclamide, or CFTRinh172. Intracellular ATP levels were
measured in total cell lysates and shown as nmoles per 104 HSPCs. Data are
expressed as mean ± SEM of six experiments. *p b 0.05. B) HSPCs were treated
with 1 μM salbutamol (or DMSO in control cells) in the absence or presence of
ICI 118,551 hydrochloride. Extracellular ATP levels were measured in con-
ditioned medium and shown as nmoles per 104 HSPCs. Data are expressed as
mean ± SEM of six experiments. SALB vs DMSO: p = 0.0723; SALB vs
ICI + SALB: p = 0.0541.
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NHERF1 in the β2-AR–CFTR interaction is still to be explored
in HSPCs. However, we have captured a glimpse of this
interaction in HSPC cell biology. In fact, salbutamol, an
agonist of β2-AR, increases CFTR activity as CFTR-dependent
chloride secretion (Fig. 4). Furthermore, salbutamol depletes
ATP content and this effect is reversed by both β2-AR and CFTR
inhibitors (Fig. 5A). These data suggest that the intracellular ATP
decrease upon β2-AR stimulation by salbutamol could be due to
CFTR activation. Indeed, to translocate Cl− across plasma cell
membrane, CFTR uses the energy generated by ATP binding and
hydrolysis at its two cytoplasmic nucleotide-binding domains
named NBD1 and NBD2 [20]. In airway epithelial cells, onagonist activation of the β2-AR, adenylyl cyclase is stimulated
through the Gs pathway [21], leading to an increase in highly
compartmentalized cAMP. This increased local concentration of
cAMP causes the activation of PKA, which is in close proximity
to CFTR [22], inducing a compartmentalized and specific
signaling of the channel. Phosphorylation of CFTR R domain
disrupts themacromolecular complex involving CFTR-NHERF1-
β2-AR, leading to the receptor-based activation of CFTR [7].
However, the number of CFTR+ HSPCs is lower than CFTR+
airway epithelial cells (15.6% ± 1.91% as compared to 68.2% ±
6.30%) as judged by FACS analysis [5]. These results, together
with the low level of mRNA expression found in HSPCs [5],
indicate that the total amount of CFTR protein in HSPCs is low
and not likely to give such an ATP consumption. This raises the
question of whether the expression of CFTR protein in the whole
HSPC population would be high enough to create a significant
decrease in intracellular ATP levels upon CFTR activation.
Moreover, activation of β2-AR results in a variety of distinct
signaling events besides activation of adenylyl cyclase, including
notably the activation of Na,K-ATPase, which would result in
further consumption of ATP. However, these metabolic processes
have been found mainly in airway epithelial cells [23] and not, to
the best of our knowledge, in HSPCs.
The reduction of intracellular ATP levels found with salbu-
tamol stimulation may be explained differently. It has been
suggested that CFTR functions as an ATP-conductive channel
based on experiments comparing the ATP release of cells over-
expressing P-glycoprotein or CFTR [24], although these results
were not reproduced in native airway tissues [25]. Nevertheless,
two studies have reported the depletion of intracellular ATP by
~30% coupled to ATP secretion upon CFTR activation in
mammary adenocarcinoma C127 cells transfected with wild-type
CFTR cDNA [26] and L6 myocytes [27]. Here we show that in
HSPCs salbutamol stimulation increases the content of extracel-
lular ATP, an effect which was blunted by the specific inhibitor of
β2-AR ICI 118,551. Thus, it might be possible that β2-AR
activation leads to ATP extrusion. However nucleotide hydro-
lyzing enzymes could have reduced the extracellular ATP
concentration. CD39, known as ectonucleoside triphosphate
diphosphohydrolase 1, which hydrolyzes extracellular ATP and
ADP to AMP, is expressed by mesenchymal stem cells obtained
from bone marrow and other various cell types [28]. Recently, it
has been shown that functional CD39 is highly expressed also by
a subset of murine and human HSPCs and is critical for
chemotaxis and recruitment of these cells from bone marrow
to the liver [29]. Notably, Prat and colleagues [26] have shown
that steady state extracellular ATP levels result not only from
ATP release but also from extracellular cleavage of ATP by
ectoATPases. Future studies will demonstrate whether CD39 is
involved in hydrolysis of extruded ATP and if this system is
relevant to HSPC biology.
Interestingly, the two subpopulations identified express
different levels of β2-AR, which may have functional conse-
quences. However, we could not investigate further this issue
since CFTR function was assessed on the whole population. We
have recently shown that the two subsets of HSPCs respond
differently to an acute lung injury as concerning their expression
33T. Trotta et al. / Journal of Cystic Fibrosis 14 (2015) 26–33of adhesion molecules and chemotactic responses. The subset
with bigger size responds better to chemotactic stimuli repre-
sented by SDF-1 [30]. Furthermore, the bigger cells displayed
less Sca-1 expression than the smaller cells, an indication of their
minor uncommitted status [5]. Further studies should elucidate
whether β2 agonists are involved in HSPC mobilization (in
particular, bigger cells) from the bone marrow to the circulation
in response to inflammatory stimuli.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.jcf.2014.08.005.
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